ScholarLens Back to search
2013•Endocrine AbstractsRequires access

Six-years experience in the treatment of the neuroendocrine tumors with the use of peptide receptor radionuclide therapy (PRRT)

Anna Sowa‐Staszczak, Agnieszka Stefańska, Monika Tomaszuk, Aleksandra Gilis‐Januszewska, Dorota Pach, Renata Mikołajczak, Alicja Hubalewska–Dydejczyk

Open publisher page 0 citations

Abstract

Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | ISSN 1479-6848 (online)

About this research paper

What this paper is about

Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | ISSN 1479-6848 (online)

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | ISSN 1479-6848 (online)

Key concepts: Radionuclide therapy, Peptide receptor, Medicine, Neuroendocrine tumors, Radionuclide, Oncology, Internal medicine, Receptor

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Six-years experience in the treatment of the neuroendocrine tumors with the use of peptide receptor radionuclide therapy (PRRT) — Research Paper | ScholarLens